Medically Reviewed · CliniqWise Clinical Advisory Board — Interventional Cardiology Panel · Updated 2026-08-27

TIMI Risk Score Calculator — NSTEMI & Unstable Angina 14-Day Mortality & MACE Risk

Calculate the TIMI risk score for patients with non-ST-elevation acute coronary syndromes (NSTEMI/UA) to predict 14-day ischemic event risk and guide invasive strategy.

🫀

TIMI Risk Score Calculator

Enter values below to calculate

This calculator is for informational and educational purposes. Results should be interpreted with clinical judgment and local guidelines.

What is the TIMI Risk Score for NSTEMI/UA?

The TIMI (Thrombolysis In Myocardial Infarction) Risk Score for Non-ST-Elevation Acute Coronary Syndromes (NSTEMI/UA) is a validated 7-point clinical prediction tool created by Antman et al. in 2000 from the TIMI 11B and ESSENCE clinical trial cohorts. It evaluates 7 independent predictor variables present at presentation: Age ≥ 65, ≥ 3 CAD risk factors, Known CAD (stenosis ≥ 50%), Aspirin use in last 7 days, Severe angina (≥ 2 episodes in 24h), ST-segment deviation ≥ 0.5mm, and Elevated cardiac biomarkers (Troponin or CK-MB). Each item scores 1 point for a total range of 0 to 7. The TIMI score predicts 14-day all-cause mortality, new or recurrent MI, or severe recurrent ischemia requiring urgent revascularization, guiding early invasive coronary angiography vs ischemia-guided conservative management under ACC/AHA guidelines.

TIMI Score = Age ≥ 65 (+1) + ≥ 3 CAD risk factors (+1) + Known CAD ≥ 50% (+1) + Aspirin use last 7d (+1) + Severe angina ≤ 24h (+1) + ST deviation ≥ 0.5mm (+1) + Positive troponin (+1). Score 0–2: Low risk (4.7–8.3%); 3–4: Intermediate (13.2–19.9%); 5–7: High risk (26.2–40.9%).

When to Use the TIMI Risk Score

  • Emergency department triage and risk stratification of patients presenting with chest pain and confirmed or suspected NSTEMI / Unstable Angina.
  • Selecting therapeutic strategy: ACC/AHA guidelines recommend an early invasive strategy (coronary angiography within 24h) for high-risk patients (TIMI ≥ 3 or GRACE > 140).
  • Guiding glycoprotein IIb/IIIa inhibitor or potent P2Y12 inhibitor (Ticagrelor/Prasugrel) selection in high-risk ACS patients.
Non-ST-Elevation Myocardial Infarction (NSTEMI)Unstable Angina (UA)Acute Coronary Syndrome (ACS)Chest Pain TriageCoronary Angiography Planning

TIMI Risk Score Criteria Breakdown (1 Point Each)

TIMI Total Score Formula

TIMI Score = Sum of 7 positive criteria (0–7 points)

Age 68 (+1) + HTN/DM/Smoking (+1) + ST depression 1mm (+1) + Elevated Troponin (+1) = Total TIMI Score 4 (Intermediate Risk)

Variables

Age ≥ 65 years (+1 point)

Patient age 65 years or older.

≥ 3 CAD Risk Factors (+1 point)

Hypertension, hypercholesterolemia, diabetes, smoking, or family history of premature CAD.

Known CAD (Stenosis ≥ 50%) (+1 point)

Prior catheterization showing ≥ 50% coronary stenosis or prior MI/CABG/PCI.

Aspirin use in past 7 days (+1 point)

Use of aspirin prior to presentation (indicates treatment failure / resistant disease).

Severe Angina (≥ 2 episodes in 24h) (+1 point)

Recurrent ischemic chest pain at rest or minimal exertion within 24 hours.

ST Deviation ≥ 0.5 mm (+1 point)

ST depression or transient ST elevation ≥ 0.5 mm on presentation ECG.

Elevated Cardiac Biomarkers (+1 point)

Positive cardiac Troponin I/T or CK-MB above local lab upper limit of normal.

Max score = 7; Min score = 0.

TIMI Score 14-Day Risk & Strategy Table

Predicts 14-day composite endpoint: All-cause mortality, new/recurrent MI, or urgent revascularization.

RangeClassificationHealth Risk
0–1 points
Low Risk
4.7–4.9% 14-day MACE. Ischemia-guided conservative management option.
2 points
Low Risk
8.3% 14-day MACE. Outpatient or conservative workup if biomarker negative.
3 points
Intermediate Risk
13.2% 14-day MACE. Early invasive strategy (angiography within 24h) recommended.
4 points
Intermediate Risk
19.9% 14-day MACE. Early invasive strategy + dual antiplatelet therapy.
5 points
High Risk
26.2% 14-day MACE. Urgent invasive angiography; intensive anti-ischemic care.
6–7 points
Very High Risk
30.9–40.9% 14-day MACE. Immediate/urgent cardiac catheterization lab transfer.

GRACE score provides superior 6-month mortality discrimination, but TIMI is faster at bedside.

Limitations & Clinical Warnings

1.

Validated ONLY for NSTEMI / Unstable Angina. Do NOT use for STEMI (use TIMI for STEMI score instead).

2.

A low TIMI score (0–1) does NOT rule out ACS; high-sensitivity troponin and clinical judgment remain essential.

3.

Does not include hemodynamic instability (hypotension, heart failure) which independently mandates emergency cardiac cath.

Medical Disclaimer

TIMI score is a risk stratification tool. Any patient with refractory chest pain or hemodynamic instability requires emergency intervention regardless of score.

References & Citations

  1. Antman EM, Cohen M, Bernink PJ, et al.. The TIMI risk score for unstable angina/non-ST elevation MI: A method for prognostication and therapeutic decision making”. JAMA. 2000. 284(7): 835–842. PMID: 10938172 | DOI: 10.1001/jama.284.7.835

Medically Reviewed

Reviewed by CliniqWise Clinical Advisory Board — Interventional Cardiology Panel · Last updated: 2026-08-27 · Next review: 2027-02-27

Frequently Asked Questions

Common Questions About TIMI Risk Score Calculator

Explore More Medical Calculators

Browse the CliniqWise calculator library by specialty, score, disease area, or clinical task.

Browse All Calculators
Support Online Now

Live Consultation

Have questions about ABDM, billing, or features? Talk to our health-tech experts instantly.